APA

Golde W. T., Burkot T. R., Piesman J., Dolan M. C., Capiau C., Hauser P., Dequesne G. & Lobet Y. (19950914). The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. : Vaccine.

Chicago

Golde W T, Burkot T R, Piesman J, Dolan M C, Capiau C, Hauser P, Dequesne G and Lobet Y. 19950914. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. : Vaccine.

Harvard

Golde W. T., Burkot T. R., Piesman J., Dolan M. C., Capiau C., Hauser P., Dequesne G. and Lobet Y. (19950914). The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. : Vaccine.

MLA

Golde W T, Burkot T R, Piesman J, Dolan M C, Capiau C, Hauser P, Dequesne G and Lobet Y. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. : Vaccine. 19950914.